Skip to main content

Month: September 2023

CLS Americas Presents its TRANBERG™ System for Image-Guided Focal Laser Ablation at Focal Therapy Society 2023 Conference

Minimally Invasive, Outpatient Treatment Designed for Quick Recovery and Low Risk of Unwanted ED and UI Side Effects WASHINGTON, Sept. 07, 2023 (GLOBE NEWSWIRE) — CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced it will exhibit its TRANBERG™ Thermal Therapy System for focal laser ablation at the Focal Therapy Society Annual Meeting 2023 being held this September 7-9, 2023 in Washington, DC. The TRANBERG system is designed to work with multiple MR/US fusion image guidance systems for precise and accurate tumor ablation in a minimally invasive, outpatient setting in a urology office or clinic. The system is FDA 510(k) cleared for soft tissue ablation in a urology setting. In the US, over one million prostate biopsies are performed every year leading to...

Continue reading

Ten Ltd. Reports Profits for the Second Quarter and Six Months Ended June 30, 2023 and Declares Total Annual Dividend of $1.00 Per Common Share for 2023

Over 350% increase in first half 2023 net income to $237 million $138 million in common stock dividend and preferred redemption so far in 2023 Long-term market fundamentals remain strong New charters secured over $1.5 billion in fleet revenue backlog 10-green vessel newbuilding program on track – Four dual-fuel aframaxes to be delivered from September 2023 to first quarter of 2024 ATHENS, Greece, Sept. 07, 2023 (GLOBE NEWSWIRE) — TEN, Ltd (TEN) (NYSE: TNP) (the “Company”) today reported results (unaudited) for the six months and second quarter ended June 30, 2023. SIX MONTHS 2023 SUMMARY RESULTSWith tanker markets remaining strong, primarily spurred by favorable supply and demand fundamentals and favorable trade dislocations caused by the war in the Ukraine continuing and with no signs of abating, TEN, in the first half of 2023,...

Continue reading

Golden Matrix Reports Third Quarter Financial Results

LAS VEGAS, NV, Sept. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Golden Matrix Group Inc. (NASDAQ:GMGI)(the “Company”, “Golden Matrix” or “GMGI”), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, today reported financial results for its third fiscal quarter ended July 31, 2023.Record quarterly revenues of $11.3 million, an increase of 24% on revenues of $9.1 million in the like year-ago quarter. Q3 net income (loss) of $(965,628) versus $628,332 in the like year-ago quarter. Revenues of $32.4 million in the first nine months of fiscal ’23, an increase of 22% on revenues of $26.5 million in the comparable year-ago period. Q3 ’23 Adjusted EBITDA of $161,783.* Net income (loss) of $(1,942,902) in the first nine months versus $1,564,695 in the comparable year-ago period. Nine-month...

Continue reading

Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update

LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its unaudited interim financial results for the six months ended June 30, 2023 and provided an update on recent corporate highlights. “The first half of 2023 was highlighted by significant updates on each of our lead rare disease programs, as we announced, alongside our partner Ultragenyx, positive data from the dose-selection Phase 2 portion of the Phase 2/3 Orbit study of setrusumab in osteogenesis imperfecta (OI), and we received regulatory guidance around the pivotal study design for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD),” said Dr. Denise Scots-Knight, Chief Executive Officer of Mereo. “With...

Continue reading

ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced that Company management will participate in the HC Wainwright 25th Annual Global Investment Conference. A webcast of the Company’s presentation will be available from the “Investors & Media” section of ProQR’s website under “Events” beginning on September 11, 2023 at 7am EDT. The archived webcast will be available for approximately 30 days. About Axiomer® ProQR is pioneering a next-generation RNA base editing technology called Axiomer®, which could potentially yield a new class of medicines for diverse types of diseases. Axiomer® “Editing Oligonucleotides”,...

Continue reading

Baker Hughes Announces Date for Third Quarter 2023 Earnings Release and Webcast

HOUSTON and LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR) will announce the results of the third quarter ending Sept. 30, 2023, via a press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Wednesday, Oct. 25, 2023. A webcast to discuss the results will be held Thursday, Oct. 26, 2023, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). To access the webcast, listeners should visit the Baker Hughes website at: investors.bakerhughes.com. An archived version will be available on the website following the webcast. About Baker Hughes:Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward...

Continue reading

GBT Receives Patent Grant Notification Covering its Integrated Circuits Reliability Verification Analysis and Auto-Correction Technology

The Patent is scheduled for Grant on September 19, 2023 SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), received a grant notification for its microchip’s reliability verification and auto-correction EDA patent application, internal project’s code name, Epsilon. The patent will be granted as U.S. Patent No. 11,763,062 on September 19, 2023. GBT’s Epsilon patent application covers the innovative technology to address advanced semiconductor node physics with the goal of ensuring a high level of reliability, optimal thermal design, lower power consumption and high performance. The described technology includes machine learning algorithms to enable robust design, process optimization, characterization, modeling, and simulation. The technology underlying the patent identifies...

Continue reading

First American Uranium Reports on New Mexico’s Past Uranium Mining and Potential at Red Basin Project

New Mexico ranks second in US-based uranium reserves The Grants district produced more uranium for 30+ years than any other US district First American Uranium’s Red Basin Uranium/Vanadium Property is located in the Grants districtVancouver, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) is pleased to provide information on past exploration and production of uranium in New Mexico, specifically in the region of the Company’s Red Basin Uranium/Vanadium Property located in the Grants district, which contains the state’s most important uranium deposits. Over 340 million pounds of U3O8 were produced from these deposits in northwestern New Mexico from 1948 to 2002, accounting for 97% of the state’s total production and exceeding...

Continue reading

Global Crossing Airlines Announces Agreement to Finance Construction of its new Maintenance Facility

MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (JET: NEO; JET.B: NEO; JETMF: OTCQB) (the “Company” or “GlobalX”) is pleased to announce that is has reached an agreement with Sheltair Aviation for the financing and construction of a new aircraft maintenance facility at the Fort Lauderdale- Hollywood International Airport (KFLL). GlobalX expects to break ground on this new facility in Q4 2023, occupy the facility in Q2 2025, and to cost approx. $25 million to construct. “We are pleased that we are partnering with Sheltair to build our maintenance home base facility. This state-of-the-art facility will cover approximately 69,650 square feet of hangar, office and shop space, providing the capability to hold three A320 family aircraft or one A330 sized aircraft. This facility is vital to our growth and...

Continue reading

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Vietnam, Strengthening Global IP Portfolio

SYDNEY, Australia, Sept. 07, 2023 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce it has been issued a trademark registration for RECCE® from the Intellectual Property Office of Vietnam, strengthening the Company’s global intellectual property (IP) portfolio. The International Trademark Registration No. 1289603 has been formally assigned to the International Bureau (World Intellectual Property Organization), classified under Class 5 for antibiotics, antibiotics for human use, and pharmaceutical preparations, namely mixed antibiotic preparations. “We are thrilled to receive this newly awarded trademark in Vietnam, further strengthening Recce’s intellectual property portfolio in the Asia-Pacific region,” said James...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.